Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Liquidia Corporation

< Previous 1 2 Next >
Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
Liquidia Corporation to Present at BofA Securities 2025 Health Care Conference
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
Liquidia Announces Poster Presentations at the American Thoracic Society (ATS) 2025 International Conference
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
Liquidia Corporation Strengthens Financial Position by Amending HealthCare Royalty Agreement to Incrementally Add Up to $100 Million
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
Liquidia to Present at the Stifel 2024 Healthcare Conference
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ Patent
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
Court Finds United Therapeutics’ Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
Liquidia Corporation Announces Raise of $67.5 Million from New Common Stock Financings and $32.5 Million Advance from HealthCare Royalty Under Current Financing Agreement
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
Liquidia to Present at Upcoming Investor Conferences
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
Liquidia Files Litigation to Challenge Regulatory Exclusivity Blocking Access to YUTREPIA™ (treprostinil) inhalation powder for Patients Suffering with PAH and PH-ILD
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
U.S. FDA Grants Tentative Approval of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
Liquidia Announces Poster Presentations at the PHA 2024 International PH Conference and Scientific Sessions
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
Liquidia Corporation Reports Second Quarter 2024 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
Liquidia Corporation to Report Second Quarter 2024 Financial Results on August 7, 2024
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
Liquidia Announces Poster Presentations at the 7th World Symposia on Pulmonary Hypertension (WSPH)
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
District Court Issues Favorable Ruling and Denies United Therapeutics’ Request to Block YUTREPIA™ Launch
From Liquidia Corporation
Via GlobeNewswire
Tickers LQDA
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.